Target intelligence / Profile preview

Gamma-aminobutyric acid type A receptor alpha-5 subunit-containing subtypes (GABA_A receptor α5)

Target
GABA_A receptor α5
Molecular classification
Ion channel, Ligand-gated ion channel, Receptor, Cys-loop ligand-gated ion-channel family
01

Overview

The GABA_A receptor α5-containing subtype is a specific class of ionotropic gamma-aminobutyric acid receptors characterized by the presence of the α5 subunit (GABRA5). These receptors are primarily localized extrasynaptically in the hippocampus and cerebral cortex, where they mediate tonic inhibition—a continuous, low-level inhibitory conductance that regulates the overall excitability of neurons [2, 5]. This tonic inhibition plays a critical role in sculpting synaptic plasticity and is essential for cognitive processes such as learning and memory [6, 10]. Dysregulation of α5-containing receptors is implicated in several neurological and psychiatric conditions; for instance, excessive tonic inhibition is associated with cognitive deficits in Alzheimer's disease, Down syndrome, and schizophrenia, while reduced receptor function is linked to autism spectrum disorders and epilepsy [2, 11]. Pharmacological targeting of this receptor involves negative allosteric modulators (NAMs) to enhance cognition by reducing tonic inhibition, and positive allosteric modulators (PAMs) which are being explored for their potential antidepressant and anxiolytic effects [12, 13].

Other names
GABRA5Gamma-aminobutyric acid receptor subunit alpha-5GABA(A) receptor subunit alpha-5Alpha5-GABA_A receptorEIEE79DEE79
02

Mechanism of action

Negative allosteric modulation (NAM), Positive allosteric modulation (PAM), and Competitive antagonism at the benzodiazepine binding site or GABA binding site.

03

Biological functions

Inhibitory neurotransmissionTonic inhibitionCognitionMemory formationSpatial learningSynaptic plasticityRegulation of neuronal excitability
04

Disease associations

Alzheimer's diseaseSchizophreniaDown syndromeCognitive impairmentAutism spectrum disorderMajor depressive disorderAngelman syndromeDup15q syndromeDevelopmental and epileptic encephalopathy 79Stroke recovery
05

Safety considerations

Pro-convulsant risk (primarily for non-selective NAMs)Sedation (for PAMs)Cognitive impairment (for PAMs)Renal toxicity (observed with specific metabolites like α5IA)Anxiogenic potential
06

Interacting drugs

Basmisanil (RG1662)

11 more in the full profile.

07

Biomarkers

[11C]Ro15-4513 (PET ligand)[11C]flumazenil (PET ligand)EEG gamma oscillationsSleep-wake behavior patterns

Beyond the preview

Go deeper on Gamma-aminobutyric acid type A receptor alpha-5 subunit-containing subtypes (GABA_A receptor α5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha-5 subunit-containing subtypes (GABA_A receptor α5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call